Ticker Details
Harvard Bioscience, Inc. Harvard Bioscience Inc is a developer, manufacturer and marketer of scientific instruments, systems and lab consumables used to advance life science for basic research, drug discovery, clinical and environmental testing.
IPO Date:	April 1, 2001
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$24.01M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 2.58%
Avg Daily Range (30 D):	$0.15 | 4.04%
Avg Daily Range (90 D):	$0.07 | 3.60%

Institutional Daily Volume
Avg Daily Volume:	.1M
Avg Daily Volume (30 D):	.17M
Avg Daily Volume (90 D):	.19M

Trade Size
Avg Trade Size (Sh.):	119
Avg Trade Size (Sh.) (30 D):	242
Avg Trade Size (Sh.) (90 D):	174

Institutional Trades
Total Institutional Trades:	159
Avg Institutional Trade:	$1.67M
Avg Institutional Trade (30 D):	$1.22M
Avg Institutional Trade (90 D):	$1.22M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$5.84M
Avg Closing Trade (30 D):	$1.22M
Avg Closing Trade (90 D):	$1.22M
Avg Closing Volume:	152.24K

News

Aug 11, 2025 @ 11:12 AM Harvard Bioscience Tops Q2 Revenue Views Source: Jesterai

Jun 2, 2025 @ 8:57 PM Harvard Bioscience Appoints John Duke to Board of ... Source: N/A

May 12, 2025 @ 11:00 AM Harvard Bioscience Announces First Quarter 2025 Fi... Source: N/A

Apr 10, 2025 @ 8:45 PM Harvard Bioscience Announces CFO Transition Source: N/A

Mar 12, 2025 @ 8:00 PM Harvard Bioscience, Inc. to Participate in Two ... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.28	$-.06	$-1.28
Diluted EPS	$-1.28	$-.06	$-1.28
Revenue	$86.55M	$23.74M	$86.55M
Gross Profit	$49.91M	$14.17M	$49.91M
Net Income / Loss	$-56.7M	$-2.85M	$-56.7M
Operating Income / Loss	$-48.58M	$1.71M	$-48.58M
Cost of Revenue	$36.64M	$9.56M	$36.64M
Net Cash Flow	$3.58M	$1.75M	$3.58M
PE Ratio

Splits
Mar 16, 2026	1:10